Yu G - Search Results

1

Cathepsin L in Lung Adenocarcinoma: Prognostic Significance and Immunotherapy Response Through a Multi Omics Perspective.

Lu J, Liang J, Xiao G, He Z, Yu G, Zhang L, Cai C, Yi G, Xie J. Lu J, et al. Among authors: yu g. Cancer Inform. 2024 Dec 16;23:11769351241307492. doi: 10.1177/11769351241307492. eCollection 2024. Cancer Inform. 2024. PMID: 39687501 Free PMC article.

2

Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients.

Liang M, Shi B, Liu J, He L, Yi G, Zhou L, Yu G, Zhou X. Liang M, et al. Among authors: yu g. Drug Des Devel Ther. 2015 Jul 16;9:3607-16. doi: 10.2147/DDDT.S85525. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26213461 Free PMC article.

3

The progresses of relevant factors on the efficacy of immune checkpoint inhibitors in the non-small cell lung cancer patients.

Yu Z, Qin L, Yu G. Yu Z, et al. Among authors: yu g. Cancer Treat Res Commun. 2023;37:100758. doi: 10.1016/j.ctarc.2023.100758. Epub 2023 Sep 12. Cancer Treat Res Commun. 2023. PMID: 37776694 Free article. Review.

4

CCT5 interacts with cyclin D1 promoting lung adenocarcinoma cell migration and invasion.

Meng Y, Yang L, Wei X, Luo H, Hu Y, Tao X, He J, Zheng X, Xu Q, Luo K, Yu G, Luo Q. Meng Y, et al. Among authors: yu g. Biochem Biophys Res Commun. 2021 Aug 27;567:222-229. doi: 10.1016/j.bbrc.2021.04.105. Epub 2021 Jul 1. Biochem Biophys Res Commun. 2021. PMID: 34217974 Free article.

5

Association between CD4⁺ T cells ATP levels and disease progression in patients with non‑small cell lung cancer.

Ye W, Hou K, Tao N, Li W, Tan Z, Huang Q, Yang D, Lin H, Deng Z, Xia Y, Yu G. Ye W, et al. Among authors: yu g. Oncol Lett. 2024 Jun 12;28(2):369. doi: 10.3892/ol.2024.14502. eCollection 2024 Aug. Oncol Lett. 2024. PMID: 38933807 Free PMC article.

6

Nuclear CD133 expression predicts poor prognosis for hepatocellular carcinoma.

Yu GF, Lin X, Luo RC, Fang WY. Yu GF, et al. Int J Clin Exp Pathol. 2018 Apr 1;11(4):2092-2099. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938317 Free PMC article.

7

Low MYH9 expression predicts a good prognosis for hepatocellular carcinoma.

Lin X, Yu GF, Zuo S, Luo RC, Fang WY. Lin X, et al. Int J Clin Exp Pathol. 2018 May 1;11(5):2784-2791. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938396 Free PMC article.

8

Mechanism of ferroptosis resistance in cancer cells.

Wang Y, Yu G, Chen X. Wang Y, et al. Among authors: yu g. Cancer Drug Resist. 2024 Nov 20;7:47. doi: 10.20517/cdr.2024.127. eCollection 2024. Cancer Drug Resist. 2024. PMID: 39624080 Free PMC article. Review.

9

Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.

Yu G, Chen X, Chen S, Ye W, Hou K, Liang M. Yu G, et al. Cancer Cell Int. 2015 Dec 12;15:116. doi: 10.1186/s12935-015-0269-y. eCollection 2015. Cancer Cell Int. 2015. PMID: 26692822 Free PMC article.

10

Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis.

Yu G, Lin J, Liu C, Hou K, Liang M, Shi B. Yu G, et al. Sci Rep. 2017 Dec 7;7(1):17176. doi: 10.1038/s41598-017-16781-9. Sci Rep. 2017. PMID: 29214989 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,153 results

Search Page

Filters